Ramin Tadayoni, MD, PhD, and Prof. Frank Holz
Show Description +
As we enter the era of biosimilars in retina, Clinical Minute: Retina host Ramin Tadayoni, MD, PhD, invites Prof. Frank Holz to update viewers on the state of biosimilars in retina. They discuss what biosimilars are, how they are approved, whether they might offer cost savings to health care systems, and which markets might be best suited for rapid biosimilar adoption.
Posted: 9/08/2023
Ramin Tadayoni, MD, PhD, and Prof. Frank Holz
As we enter the era of biosimilars in retina, Clinical Minute: Retina host Ramin Tadayoni, MD, PhD, invites Prof. Frank Holz to update viewers on the state of biosimilars in retina. They discuss what biosimilars are, how they are approved, whether they might offer cost savings to health care systems, and which markets might be best suited for rapid biosimilar adoption.
Posted: 9/08/2023
Please log in to leave a comment.